Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea.
10.3346/jkms.2014.29.7.980
- Author:
So Hyun BAE
1
;
Min Jung PARK
;
Min Mi LEE
;
Tae Min KIM
;
Se Hoon LEE
;
Sung Yun CHO
;
Young Hoon KIM
;
Yu Jung KIM
;
Chul Kee PARK
;
Chae Yong KIM
Author Information
1. Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea. chaeyong@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Glioma;
Temozolomide;
Toxicity;
Chemoradiotherapy;
Chemotherapy, Adjuvant
- MeSH:
Adolescent;
Adult;
Aged;
Aged, 80 and over;
Anorexia/etiology;
Antineoplastic Agents, Alkylating/adverse effects/*therapeutic use;
Brain Neoplasms/*drug therapy/pathology/radiotherapy;
Dacarbazine/adverse effects/*analogs & derivatives/therapeutic use/toxicity;
Female;
Glioma/*drug therapy/pathology/radiotherapy;
Hematologic Diseases/etiology;
Humans;
Male;
Middle Aged;
Nausea/drug therapy/etiology;
Neoplasm Staging;
Republic of Korea;
Retrospective Studies;
Severity of Illness Index;
Sex Factors;
Vomiting/drug therapy/etiology;
Young Adult
- From:Journal of Korean Medical Science
2014;29(7):980-984
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study evaluated the toxicity profiles of temozolomide in the treatment of malignant glioma as either concurrent or adjuvant chemotherapy. We retrospectively reviewed the medical records of 300 malignant glioma patients treated with temozolomide in two medical institutions in Korea between 2004 and 2010. Two hundred nine patients experienced a total of 618 toxicities during temozolomide therapy. A total of 84.8% of the 618 toxicities were Common Terminology Criteria for Adverse Events (CTCAE) grade 1 or 2, while 15.2% were grade 3 or 4. Among the hematologic toxicities, thrombocytopenia (13.7%), anemia (11.0%), and AST/ALT increases (7.0%) were common. Among the non-hematologic toxicities, nausea (44.3%), vomiting (37.0%), and anorexia (14.3%) were the three most common toxicities. There was no mortality due to temozolomide. Although temozolomide showed many types of toxicities, the majority of the toxicities were tolerable and of lower grade. Gastrointestinal troubles are the most common toxicities in Korean patients treated with temozolomide.
